Cairn Investment Group Inc. Acquires 225 Shares of Cardinal Health, Inc. $CAH

Cairn Investment Group Inc. raised its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 1.9% during the second quarter, according to its most recent filing with the SEC. The firm owned 12,192 shares of the company’s stock after purchasing an additional 225 shares during the period. Cairn Investment Group Inc.’s holdings in Cardinal Health were worth $2,048,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of CAH. JPMorgan Chase & Co. raised its stake in Cardinal Health by 40.0% in the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock worth $575,327,000 after buying an additional 1,193,983 shares in the last quarter. Northern Trust Corp lifted its holdings in Cardinal Health by 3.5% during the first quarter. Northern Trust Corp now owns 3,143,003 shares of the company’s stock worth $433,012,000 after buying an additional 105,154 shares during the period. Wellington Management Group LLP boosted its position in Cardinal Health by 1,666.7% during the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock valued at $328,470,000 after acquiring an additional 2,249,241 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of Cardinal Health by 3.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,654,036 shares of the company’s stock valued at $227,877,000 after acquiring an additional 52,714 shares during the period. Finally, Dimensional Fund Advisors LP increased its holdings in shares of Cardinal Health by 0.6% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,246,788 shares of the company’s stock valued at $171,749,000 after acquiring an additional 7,940 shares during the period. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Insider Buying and Selling

In related news, insider Ola M. Snow sold 28,151 shares of the stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total value of $4,192,809.94. Following the completion of the sale, the insider owned 15,431 shares of the company’s stock, valued at approximately $2,298,293.14. This trade represents a 64.59% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Michelle D. Greene sold 13,500 shares of the firm’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $2,009,070.00. Following the completion of the sale, the insider directly owned 14,976 shares of the company’s stock, valued at $2,228,728.32. This trade represents a 47.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 271,676 shares of company stock worth $40,489,525 in the last ninety days. Company insiders own 0.12% of the company’s stock.

Cardinal Health Trading Up 3.3%

Shares of CAH stock opened at $153.84 on Monday. Cardinal Health, Inc. has a twelve month low of $106.98 and a twelve month high of $168.44. The stock has a market cap of $36.55 billion, a P/E ratio of 23.85, a P/E/G ratio of 1.30 and a beta of 0.73. The stock has a 50 day moving average of $152.20 and a 200 day moving average of $149.61.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating the consensus estimate of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm had revenue of $60.16 billion during the quarter, compared to analyst estimates of $60.91 billion. During the same quarter in the previous year, the business earned $1.84 EPS. Cardinal Health’s revenue for the quarter was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, research analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be issued a dividend of $0.5107 per share. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. Cardinal Health’s dividend payout ratio is presently 31.63%.

Analysts Set New Price Targets

A number of brokerages recently weighed in on CAH. Jefferies Financial Group set a $150.00 price objective on Cardinal Health in a research report on Tuesday, August 12th. Robert W. Baird raised their price target on shares of Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a report on Wednesday, August 13th. Citigroup reiterated a “neutral” rating and set a $170.00 price objective (up previously from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. Wall Street Zen downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 2nd. Finally, Wells Fargo & Company reaffirmed an “overweight” rating and issued a $185.00 price target (up from $183.00) on shares of Cardinal Health in a report on Wednesday, August 13th. Eleven analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus price target of $165.93.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.